Bulletin
Investor Alert

New York Markets Open in:

Revolution Medicines Inc.

NAS: RVMD

GO
/marketstate/country/us

After Hours

/zigman2/quotes/216320743/composite

$

18.50

Change

0.00 0.00%

Volume

Volume 11,293

Jun 27, 2022, 4:51 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/216320743/composite

Previous close

$ 18.87

$ 18.50

Change

-0.37 -1.96%

Day low

Day high

$18.39

$18.93

Open
Open: 18.89

52 week low

52 week high

$14.08

$34.16

Open

Market cap

$1.40B

Average volume

774,638

P/E ratio

N/A

Rev. per Employee

$156,330

EPS

-2.81

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/rvmd

MarketWatch News on RVMD

  1. Revolution Medicines started at neutral with $24 stock price target at BofA Securities

    10:24 a.m. May 20, 2022

    - Tomi Kilgore

  2. Revolution Medicines started at hold with $34 stock price target at Stifel Nicolaus

    7:43 a.m. Sept. 23, 2021

    - Tomi Kilgore

  3. Cancer Meeting Could Ignite These Biotech Stocks

    6:00 a.m. Oct. 24, 2020

    - Barron's Online

  4. The Pandemic Speeds Up the Health-Care Revolution

    6:01 p.m. Oct. 6, 2020

    - Barron's Online

  5. Cancer Meeting’s High Hopes for Amgen and Gilead

    8:22 a.m. Sept. 21, 2020

    - Barron's Online

  6. Why Blackstone Stock Looks Attractive

    10:29 p.m. May 22, 2020

    - Barron's Online

  7. Revolution Medicines shares soar 85% in trading debut

    12:16 p.m. Feb. 13, 2020

    - Ciara Linnane

  8. Revolution Medicines prices IPO at $17 a share

    8:56 p.m. Feb. 12, 2020

    - Jeremy C. Owens

  9. Revolution Medicines increases size of planned IPO and raises price range

    8:07 a.m. Feb. 11, 2020

    - Ciara Linnane

  10. Revolution Medicines to offer 14 mln shares in planned IPO, priced at $16 to $17 each

    8:07 a.m. Feb. 11, 2020

    - Ciara Linnane

/news/nonmarketwatch/company/us/rvmd

Other News on RVMD

  1. Pacira (PCRX) Q4 Earnings and Revenues Beat Estimates

    10:25 a.m. Feb. 24, 2022

    - Zacks.com

  2. Revolution Medicines (RVMD) Investor Presentation - Slideshow

    10:42 a.m. Feb. 12, 2022

    - Seeking Alpha

  3. Warning: RVMD is at high risk of performing badly

    5:33 a.m. Dec. 25, 2021

    - Seeking Alpha

  4. Warning: RVMD is at high risk of performing badly

    5:33 a.m. Dec. 10, 2021

    - Seeking Alpha

  5. Loading more headlines...
/news/pressrelease/company/us/rvmd

Press Releases on RVMD

  1. Tuesday 3/22 Insider Buying Report: PCT, RVMD

    11:14 a.m. March 22, 2022

    - MarketNewsVideo.com

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.